genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Gene Therapy
At Orchard, Moving from Pruning to Planting
GEN Edge
Massachusetts Biopharma Industry Weathers COVID-19 Impacts on Jobs, Financing
AAV (Adeno-associated virus)
Quartet of COVID-19 Vaccine Candidates Head toward the Homestretch
Coronavirus
Rough Surf Ahead for California
Cancer
Alpine’s Gold Standard Approach to Drug Development
News
OMICs
New Model May Help in Successfully Translating Data from Animal Studies…
Autism
Autistic Men Have Enhanced Excitability in Social Brain Regions
Gene Therapy
Researchers Uncover How Certain Gliomas Develop Resistance
OMICs
Core Set of Muscle-Building Genes Identified through Novel Human Study
Bioprocessing
Waisman Biomanufacturing Partners with Heat Biologics on COVID-19 Vaccine Manufacture
Insights
All
Trends for 2020
Bioprocessing
Remote Control of CAR T Cells to Enhance Safety
Bioprocessing
Standardizing Cell and Gene Therapy Remains Bioindustry Goal
Bioprocessing
COVID-19 Increases Demand for Next-Generation Bioprocessing Technology
Bioprocessing
Moving Quickly but Smartly from R&D to Commercialization
A-Lists
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Coronavirus
Catching Up to Coronavirus: Top 60 Treatments in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
OMICs
New Model May Help in Successfully Translating Data from Animal Studies…
Bioprocessing
Remote Control of CAR T Cells to Enhance Safety
Gene Therapy
Researchers Uncover How Certain Gliomas Develop Resistance
OMICs
Core Set of Muscle-Building Genes Identified through Novel Human Study
Magazine
July 2020 Vol. 40 No. 7
Rosalind Franklin the Scientist
July 2020 Vol. 40 No. 7
COVID-19 Research: Women Are Changing the Face of the Pandemic
July 2020 Vol. 40 No. 7
CRISPR Screening Explores New Dimensions
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
Commentary
Clues to Healthier Aging in Cellular Senescence
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Tutorial
In-Depth GPCR Signaling Characterization for Improved Drug Discovery
New Products
Precoated Plates
New Products
Liquid Chromatograph Mass Spectrometer
New Products
RNA Quantification Assay
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Cancer
Lymphoma
Lymphoma
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Lymphoma
Lymphoma-Associated Metabolic Enzyme May Be a Drug Target
Lymphoma
Gilead to Acquire Forty Seven for $4.9B, Expanding Immuno-Oncology Pipeline
Lymphoma
Engineered Probiotic Bacteria Deliver Anticancer Nanobodies to Regress Tumors in Mice
Lymphoma
Jakafi Success Helps Incyte Land Blockbuster MorphoSys Partnership
Lymphoma
Catalent Agrees to Manufacture BeiGene’s Tyrosine Kinase Inhibitor for Lymphoma Therapy
Lymphoma
Allogene, Notch Partner to Develop iPSC-Derived Blood Cancer Therapies
Lymphoma
Janssen, Genmab Partner on Follow-On to Darzalex for Multiple Myeloma, Diffuse...
Lymphoma
Lymphoma Resistance Mechanism to Chemo Drug Identified
Lymphoma
Cancer Drug Developers GTx, Oncternal Plan Reverse Merger
Lymphoma
FDA Approves First Non-Chemo Combination Therapy for a Form of Leukemia
Lymphoma
Harbour BioMed to Develop Kelun-Biotech’s Cancer Immunotherapy Candidate A167
Lymphoma
Epizyme Halts Phase II Trial of Tazemetostat in DLBCL Cohorts, Continues...
Lymphoma
Aggressive Lymphoma Linked with JAK Inhibitor Use
Lymphoma
FDA Imposes Partial Clinical Hold on Epizyme Lead Candidate after Patient...
Lymphoma
MorphoSys to Advance Pipeline, Platform Through Up-to-$150M U.S. IPO
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
